Vanessa Morris1, Herry Patel1, Lana Vedelago1, Derek D Reed2, Jane Metrik3,4, Elizabeth Aston3, James MacKillop1,5,6, Michael Amlung1,6. 1. Peter Boris Centre for Addictions Research, McMaster University & St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada. 2. Department of Applied Behavioral Science, Kansas University, Lawrence, Kansas. 3. Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island. 4. Providence Veterans Affairs Medical Center, Providence, Rhode Island. 5. Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, Ontario, Canada. 6. Homewood Research Institute, Guelph, Ontario, Canada.
Abstract
OBJECTIVE: Co-use of cannabis and alcohol is associated with increased drinking and other negative consequences relative to use of alcohol alone. One potential explanation for these differences is overvaluation of alcohol (e.g., alcohol demand) among co-users, similar to established overvaluation of alcohol among tobacco and alcohol co-users. This study examined differences in alcohol demand between an alcohol and cannabis co-user group and an alcohol-only group. METHOD: A large sample of adult drinkers (n = 1,643, 54% female) was recruited through an online crowdsourcing site (Amazon Mechanical Turk). Of the full sample, 476 participants reported weekly or greater cannabis use in the past 6 months (co-user group); 888 reported never using cannabis in the past 6 months (alcohol-only group). Assessments included a validated alcohol purchase task and self-report measures of alcohol and cannabis use. RESULTS: Co-users reported significantly higher alcohol consumption across the elastic portion of the alcohol demand curve (i.e., $1.50-$9.00/drink). Analyses of covariance controlling for alcohol use and demographics revealed significantly higher breakpoint (p = .025) and Omax (p = .002) and significantly lower elasticity (p < .003) in the co-user group. Intensity and Pmax did not significantly differ between groups. CONCLUSIONS: Co-users of cannabis and alcohol overvalue alcohol compared with individuals who drink alcohol but do not use cannabis. This study is generally consistent with prior studies on alcohol and tobacco co-users, providing converging evidence that polysubstance use is associated with overvaluation of alcohol. These findings have important implications for treatment and prevention, particularly in the context of changes in cannabis legalization.
OBJECTIVE: Co-use of cannabis and alcohol is associated with increased drinking and other negative consequences relative to use of alcohol alone. One potential explanation for these differences is overvaluation of alcohol (e.g., alcohol demand) among co-users, similar to established overvaluation of alcohol among tobacco and alcohol co-users. This study examined differences in alcohol demand between an alcohol and cannabis co-user group and an alcohol-only group. METHOD: A large sample of adult drinkers (n = 1,643, 54% female) was recruited through an online crowdsourcing site (Amazon Mechanical Turk). Of the full sample, 476 participants reported weekly or greater cannabis use in the past 6 months (co-user group); 888 reported never using cannabis in the past 6 months (alcohol-only group). Assessments included a validated alcohol purchase task and self-report measures of alcohol and cannabis use. RESULTS: Co-users reported significantly higher alcohol consumption across the elastic portion of the alcohol demand curve (i.e., $1.50-$9.00/drink). Analyses of covariance controlling for alcohol use and demographics revealed significantly higher breakpoint (p = .025) and Omax (p = .002) and significantly lower elasticity (p < .003) in the co-user group. Intensity and Pmax did not significantly differ between groups. CONCLUSIONS: Co-users of cannabis and alcohol overvalue alcohol compared with individuals who drink alcohol but do not use cannabis. This study is generally consistent with prior studies on alcohol and tobacco co-users, providing converging evidence that polysubstance use is associated with overvaluation of alcohol. These findings have important implications for treatment and prevention, particularly in the context of changes in cannabis legalization.
Authors: Jeffrey S Stein; Mikhail N Koffarnus; Sarah E Snider; Amanda J Quisenberry; Warren K Bickel Journal: Exp Clin Psychopharmacol Date: 2015-07-06 Impact factor: 3.157
Authors: Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis Journal: Clin Chem Date: 2015-05-27 Impact factor: 8.327
Authors: Victor Martínez-Loredo; Alba González-Roz; Roberto Secades-Villa; José R Fernández-Hermida; James MacKillop Journal: Addiction Date: 2021-01-15 Impact factor: 7.256
Authors: ReJoyce Green; James MacKillop; Emily E Hartwell; Aaron C Lim; Wave-Ananda Baskerville; Mitchell Karno; Lara A Ray Journal: Nicotine Tob Res Date: 2021-03-19 Impact factor: 5.825
Authors: Kevin W Campbell; Andrew T Voss; Samuel F Acuff; Kinsey Pebley; Kristoffer S Berlin; Matthew P Martens; Brian Borsari; Ashley A Dennhardt; James G Murphy Journal: Exp Clin Psychopharmacol Date: 2020-07-30 Impact factor: 3.157